Stockreport

Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF BRISBANE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, devel [Read more]